DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase

Epigenetics. 2018;13(1):95-107. doi: 10.1080/15592294.2017.1414128. Epub 2018 Feb 7.

Abstract

Patterns of DNA methylation, an important epigenetic modification involved in gene silencing and development, are disrupted in cancer cells. Understanding the functional significance of aberrant methylation in tumors remains challenging, due in part to the lack of suitable tools to actively modify methylation patterns. DNA demethylation caused by mammalian DNA methyltransferase inhibitors is transient and replication-dependent, whereas that induced by TET enzymes involves oxidized 5mC derivatives that perform poorly understood regulatory functions. Unlike animals, plants possess enzymes that directly excise unoxidized 5mC from DNA, allowing restoration of unmethylated C through base excision repair. Here, we show that expression of Arabidopsis 5mC DNA glycosylase DEMETER (DME) in colon cancer cells demethylates and reactivates hypermethylated silenced loci. Interestingly, DME expression causes genome-wide changes that include both DNA methylation losses and gains, and partially restores the methylation pattern observed in normal tissue. Furthermore, such methylome reprogramming is accompanied by altered cell cycle responses and increased sensibility to anti-tumor drugs, decreased ability to form colonospheres, and tumor growth impairment in vivo. Our study shows that it is possible to reprogram a human cancer DNA methylome by expression of a plant DNA demethylase.

Keywords: DNA demethylation; DNA methylation; Epigenetics; base excision repair; colon cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Arabidopsis Proteins / genetics*
  • Arabidopsis Proteins / metabolism
  • Cell Cycle / drug effects
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • DNA Methylation*
  • DNA Repair / genetics
  • Fluorouracil / pharmacology
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Genes, p16
  • Humans
  • Mice, Nude
  • N-Glycosyl Hydrolases / genetics*
  • N-Glycosyl Hydrolases / metabolism
  • Oncogene Proteins / genetics
  • Oxaliplatin / pharmacology
  • Receptor Tyrosine Kinase-like Orphan Receptors / genetics
  • Trans-Activators / genetics*
  • Trans-Activators / metabolism
  • Transgenes
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Arabidopsis Proteins
  • CDK2AP2 protein, human
  • Oncogene Proteins
  • Trans-Activators
  • Oxaliplatin
  • ROR2 protein, human
  • Receptor Tyrosine Kinase-like Orphan Receptors
  • DEMETER protein, Arabidopsis
  • N-Glycosyl Hydrolases
  • Fluorouracil

Grants and funding

This work was supported by Junta Andalucía [grant number P11-CVI-7576]; Spanish Ministry of Science [grant number BFU2016-80728-P]; Plan Nacional de I+D+I 2013-2016/FEDER [grant number PI15/00892]; Asturias Regional Goverment [grant number GRUPIN14-052].